- Home
- NBIX vs LBRDA Comparison
NBIX vs LBRDA Comparison
Compare NBIX & LBRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- LBRDA
- Stock Information
- Founded
- NBIX 1992
- LBRDA 2014
- Country
- NBIX United States
- LBRDA United States
- Employees
- NBIX N/A
- LBRDA N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- LBRDA Cable & Other Pay Television Services
- Sector
- NBIX Health Care
- LBRDA Telecommunications
- Exchange
- NBIX Nasdaq
- LBRDA Nasdaq
- Market Cap
- NBIX 12.4B
- LBRDA 13.4B
- IPO Year
- NBIX 1996
- LBRDA N/A
- Fundamental
- Price
- NBIX $134.33
- LBRDA $95.10
- Analyst Decision
- NBIX Strong Buy
- LBRDA Buy
- Analyst Count
- NBIX 21
- LBRDA 2
- Target Price
- NBIX $165.14
- LBRDA $105.00
- AVG Volume (30 Days)
- NBIX 821.3K
- LBRDA 163.2K
- Earning Date
- NBIX 07-30-2025
- LBRDA 08-07-2025
- Dividend Yield
- NBIX N/A
- LBRDA N/A
- EPS Growth
- NBIX N/A
- LBRDA 6.21
- EPS
- NBIX 2.96
- LBRDA 6.26
- Revenue
- NBIX $2,412,600,000.00
- LBRDA $1,037,000,000.00
- Revenue This Year
- NBIX $16.29
- LBRDA $5.22
- Revenue Next Year
- NBIX $15.08
- LBRDA $2.34
- P/E Ratio
- NBIX $45.11
- LBRDA $15.55
- Revenue Growth
- NBIX 21.73
- LBRDA 5.82
- 52 Week Low
- NBIX $84.23
- LBRDA $52.48
- 52 Week High
- NBIX $157.98
- LBRDA $102.38
- Technical
- Relative Strength Index (RSI)
- NBIX 70.92
- LBRDA 51.06
- Support Level
- NBIX $127.03
- LBRDA $96.31
- Resistance Level
- NBIX $135.94
- LBRDA $101.00
- Average True Range (ATR)
- NBIX 2.85
- LBRDA 2.20
- MACD
- NBIX 0.47
- LBRDA -0.02
- Stochastic Oscillator
- NBIX 87.52
- LBRDA 44.30
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About LBRDA Liberty Broadband Corporation
Liberty Broadband Corp serves in the telecommunications industry in the United States. It provides cable services to both residential andsommercial businesses through its fiber, hybrid fiber, and coaxial cable infrastructure. The services provided by the company are residential services which include video services, internet services, voice services, and mobile services, commercial services which include small, and medium business and enterprise solutions, advertising services, and other services. The reportable segments of the company are GCI Holdings, Charter. The firm derives the majority of its revenue from GCI Holdings.